Boundless Bio Eulerpool News

Boundless Bio Stock News

Boundless Bio is being monitored by journalists and investors worldwide. We gather the latest Boundless Bio news here.

• March 20 ·

  SeekingAlpha
  Boundless Bio: An Underestimated Biotech With A First-In-Class EcDNA Targeted Kinesin Degrader
• February 9 ·

  Benzinga
  12 Health Care Stocks Moving In Monday's Pre-Market Session
• January 20 ·

  Yahoo
  Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway
• October 13 ·

  Yahoo
  Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
• August 5 ·

  Yahoo
  Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights
• August 5 ·

  Benzinga
  Boundless Bio Q2 EPS $(0.70) Beats $(0.71) Estimate
• June 2 ·

  Benzinga
  HC Wainwright & Co. Initiates Coverage On Boundless Bio with Buy Rating, Announces Price Target of $5
• May 28 ·

  Benzinga
  Leerink Partners Downgrades Boundless Bio to Market Perform, Lowers Price Target to $3
• May 23 ·

  Benzinga
  Boundless Bio Announces Portfolio Prioritization And Runway Extension; Prioritizes BBI-355/BBI-825 Combination And BBI-940; Discontinues Current Arms Of BBI-355 In Potentiate Trial; To Evaluate BBI-355/BBI-825 Combination In 2025; Reduces Workforce By One-Third
• May 9 ·

  Yahoo
  Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

Boundless Bio Stock Press Releases

Boundless Bio regularly publishes news on the company's website that are relevant for investors.